Jade Biosciences

Jade Biosciences (operating at jadebiosciences.com) is a biotechnology company engineered for developing transformative therapies aimed at transforming the standard of care for patients living with autoimmune diseases. Founded in 2024 by unknown founders and headquartered in Waltham, MA, United States, Jade Biosciences addresses critical unmet needs in autoimmune diseases. Under the hood, the company develops a pipeline of potentially best-in-class therapies. This allows patients to receive potentially best-in-class treatments. Backed by a $300 million financing, led by Fairmount and Venrock Healthcare Capital Partners.